Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases?
暂无分享,去创建一个
[1] T. Poynard,et al. FibroMAX™: towards a new universal biomarker of liver disease? , 2007, Expert review of molecular diagnostics.
[2] P. Tan,et al. Identification of Circulating MicroRNA Signatures for Breast Cancer Detection , 2013, Clinical Cancer Research.
[3] S. Hébert,et al. Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers , 2013, Front. Mol. Neurosci..
[4] Marcel Scheideler,et al. Overexpression of primary microRNA 221/222 in acute myeloid leukemia , 2013, BMC Cancer.
[5] P. Doevendans,et al. Circulating MicroRNA Profiles for Detection of Peripheral Arterial Disease: Small New Biomarkers for Cardiovascular Disease , 2013, Circulation. Cardiovascular genetics.
[6] Martial Saugy,et al. Circulating miRNAs: a new generation of anti-doping biomarkers , 2013, Analytical and Bioanalytical Chemistry.
[7] Kira S. Sheinerman,et al. Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies , 2013, Front. Cell. Neurosci..
[8] Yoshiki Murakami,et al. Principal Component Analysis Based Feature Extraction Approach to Identify Circulating microRNA Biomarkers , 2013, PloS one.
[9] Gottfried Köhler,et al. Interleukin 8 (IL-8) - a universal biomarker? , 2010, International archives of medicine.
[10] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[11] J Waxman,et al. Circulating microRNAs as potential new biomarkers for prostate cancer , 2013, British Journal of Cancer.
[12] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[13] S. Ricci,et al. Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[14] K. Jellinger,et al. Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker? , 2008, Journal of cellular and molecular medicine.
[15] Sabine C. Mueller,et al. A blood based 12-miRNA signature of Alzheimer disease patients , 2013, Genome Biology.
[16] Zoltan Dezso,et al. Circulating miRNA Biomarkers for Alzheimer's Disease , 2013, Alzheimer's & Dementia.
[17] Ron Wehrens,et al. Stability-based biomarker selection. , 2011, Analytica chimica acta.
[18] O. Slabý,et al. Circulating miRNAs as new blood-based biomarkers for solid cancers. , 2013, Future oncology.
[19] C. Woods,et al. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. , 2013, Blood.
[20] E. Petricoin,et al. The blood peptidome: a higher dimension of information content for cancer biomarker discovery , 2006, Nature Reviews Cancer.
[21] P. Doevendans,et al. Circulating MicroRNAs as Novel Biomarkers for the Early Diagnosis of Acute Coronary Syndrome , 2013, Journal of Cardiovascular Translational Research.
[22] R. Biondi,et al. Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers , 2013, PloS one.
[23] D. Engelman,et al. pHLIP and Acidity as a Universal Biomarker for Cancer , 2012, The Yale journal of biology and medicine.
[24] Christian Langer,et al. Circulating microRNAs in hematological diseases: principles, challenges, and perspectives. , 2013, Blood.
[25] A. Krishnamurthy,et al. Lung cancer detection by screening - presenting circulating miRNAs as a promising next generation biomarker breakthrough. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[26] Antai Wang,et al. Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma: MiR-483-5p as a Potential Biomarker , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[27] Yoshiki Murakami,et al. Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose Liver Disease , 2012, PloS one.
[28] C. Garnis,et al. Differential expression of miRNAs in the serum of patients with high-risk oral lesions , 2012, Cancer medicine.
[29] Martin Reczko,et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways , 2012, Nucleic Acids Res..
[30] Sandip Chaugai,et al. Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis , 2013, Journal of Translational Medicine.
[31] S. Hanash,et al. Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer , 2011, Nature Reviews Clinical Oncology.
[32] Thomas Tuschl,et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations , 2013, Proceedings of the National Academy of Sciences.